Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg

Clinical trial NCT01918358 · COMPLETED

Trial details

NCT number: NCT01918358
Sponsor: LG Life Sciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension Hyperlipidemia

Start date: 2012-12-01
Primary completion: 2013-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.